ATC Code D11AX18, M01AB05, M02AA15, S01BC03
Formula C14H11Cl2NO2
Molar Mass (g·mol−1) 296,15
Physical State solid
Melting Point (°C) 280
PKS Value 4,15
CAS Number 15307-86-5
PUB Number 3033
Drugbank ID DB00586
Solubility insoluble in water


Diclofenac is a commonly used drug from the group of non-steroidal anti-inflammatory drugs (NSAIDs). It is used to treat mild to moderate pain and inflammation, mainly after injuries such as bruises or strains. Diclofenac is most commonly administered in the sodium salt form. Common dosage forms include gels and ointments for external use, as well as tablets. Diclofenac is available by prescription in certain dosage forms.



Diclofenac works by inhibiting a specific enzyme in the body. This enzyme, cyclooxygenase, is instrumental in the development of pain. Diclofenac binds to the enzyme and inhibits its function, thereby preventing the synthesis of prostaglandins. Prostaglandins mediate inflammatory processes, which subsequently lead to the development of pain. This results in the analgesic, anti-inflammatory and also antipyretic effect of diclofenac.


Diclofenac is absorbed in the GI tract, but experiences a strong "first-pass effect", which is why only about 60% reaches the bloodstream. For this reason, diclofenac is most commonly applied to the skin, as this circumvents the "first-pass effect". The maximum plasma concentration is reached after 1-2 hours on average. Diclofenac is 99% bound to plasma proteins and is mainly metabolized by the liver. Excretion is 70% by the kidneys and 30% by the stool.

Drug Interactions

Concomitant administration of other NSAIDs or glucocorticoids may increase the risk of gastrointestinal bleeding. Diclofenac may inhibit the action of diuretics and angiotensin II antagonists. Diclofenac may increase serum levels of lithium, phenytoin and cardiac glycosides.


Side effects

The typical side effects involve the gastrointestinal tract and include, for example, abdominal pain and nausea, as well as bleeding.

Other side effects are:

  • Vomiting
  • Diarrhoea
  • Flatulence
  • constipation
  • indigestion
  • abdominal pain
  • tarry stools
  • Hematemesis

Toxicological data

LD50 (rat, oral): 62.5 mg-kg-1

Markus Falkenstätter

Markus Falkenstätter

Markus Falkenstätter ist Autor zu pharmazeutischen Themen in der Medizin-Redaktion von Medikamio. Er befindet sich im letzten Semester seines Pharmaziestudiums an der Universität Wien und liebt das wissenschaftliche Arbeiten im Bereich der Naturwissenschaften.

Mag. pharm Stefanie Lehenauer

Mag. pharm Stefanie Lehenauer

Stefanie Lehenauer ist seit 2020 freie Autorin bei Medikamio und studierte Pharmazie an der Universität Wien. Sie arbeitet als Apothekerin in Wien und ihre Leidenschaft sind pflanzliche Arzneimittel und deren Wirkung.

Your personal medicine assistent

afgis-Qualitätslogo mit Ablauf Jahr/Monat: Mit einem Klick auf das Logo öffnet sich ein neues Bildschirmfenster mit Informationen über Medikamio GmbH & Co KG und sein/ihr Internet-Angebot: medikamio.com/ This website is certified by Health On the Net Foundation. Click to verify.

Search our database for drugs, sorted from A-Z with their effects and ingredients.


All substances with their common uses, chemical components and medical products which contain them.


Causes, symptoms and treatment for the most common diseases and injuries.

The contents shown do not replace the original package insert of the medicinal product, especially with regard to dosage and effect of the individual products. We cannot assume any liability for the correctness of the data, as the data was partly converted automatically. A doctor should always be consulted for diagnoses and other health questions. Further information on this topic can be found here.